Is intracavernous injection of XXXX a reliable screening test for vascular @entity323 ?

@entity1 @entity323 @entity455 @entity16 @entity3327 @entity3302
To determine whether intracavernous injection of @entity3302 can discriminate vascular versus psychogenic @entity323 80 mg. @entity3302 were injected intracorporeally into 27 impotent @entity1 without any hormonal or @entity16 . The @entity1 also underwent dynamic cavernosography, the artificial erection test and selective internal iliac arteriography. In addition, 21 of the @entity1 underwent nocturnal penile tumescence monitoring. The response to intracavernous @entity3302 injection was noted as positive (fully rigid erection), intermediate or negative (soft or absent erection). Among 14 @entity1 with severe @entity455 and/or severe venous leakage the response was negative in 11 and positive in none. Among the remaining 13 @entity1 (moderate or @entity455 ) the response was positive in 4 but negative in 4. Of 15 @entity1 with an abnormal nocturnal penile tumescence test the response to intracavernous @entity3302 injection was negative in 12 and positive in none. However, of 6 @entity1 with a normal nocturnal penile tumescence test the response was positive in only 1. Over-all, the results of the intracavernous @entity3302 injection test are correlated only fairly with those of the nocturnal penile tumescence test and the vascular investigations. This test could be useful to save some nocturnal penile tumescence tests in cases of suspected vascular @entity323 . However, the safety of this procedure must be confirmed in larger series. Indeed, 1 of our @entity1 suffered @entity3327 after a second intracavernous @entity3302 injection performed for a therapeutic purpose.
